3630 results for «843»
3630 results
From 3D coronary imaging to calcium modification, the future of PCI starts now
21 May 2026 – From EuroPCR 2026
This session delves into the cutting-edge integration of 3D coronary imaging and calcium modification techniques in percutaneous coronary intervention (PCI). Participants will understand how 3DStent visualization enhances PCI optimization beyond conventional angiography, learn to characterize coronary calcification pre-PCI using advanced imaging tools, and incorporate practical workflows...
The metal-free strategy: shaping the new era of hybrid vessel restoration with DCB and BRS
19 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session explores the emerging metal-free strategy in coronary intervention, combining drug-coated balloons (DCB) and bioresorbable scaffolds (BRS) to support a “leave-nothing-behind” approach to vessel restoration.
It focuses on lesion preparation, scaffold sizing and deployment, and the integration of hybrid therapies to optimise procedural outcomes....
Contemporary workflow for class IA PCI
19 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session presents a contemporary workflow for Class IA PCI, focusing on how coronary physiology can be used to better understand disease patterns and guide procedural strategy in complex interventions.
It explores the role of physiological assessment in refining decision-making, alongside new co- and tri-registration...
Rethinking stentless PCI strategy - Improving outcomes with Bioadaptor
19 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session explores contemporary PCI strategies through the concept of stentless intervention using the Bioadaptor device in complex coronary disease.
It highlights the bioadaptive design features of Bioadaptor and reviews the supporting clinical evidence, with a focus on how this technology may influence procedural outcomes.
The...
Beyond the horizon - A prelude into TAVI and complex PCI solutions
19 May 2026 – From EuroPCR 2026
This session provides a comprehensive preview of evolving technologies and strategies shaping interventional cardiology. Discover the Myval Octapro+ transcatheter heart valve (THV) and its innovative design and procedural benefits demonstrated through a recorded case. Stay updated on Landmark and Compare TAVI trial data, and discover the...
TAVI and coronary artery disease: we need the COMPLETE answer!
19 May 2026 – From EuroPCR 2026
Addressing the intersection of transcatheter aortic valve implantation (TAVI) and coronary artery disease, this session reviews contemporary surgical and interventional literature to elucidate current practices. It underscores the need for a large international randomized controlled trial to provide definitive guidance for managing patients with concomitant aortic...
Large-bore venous access and vessel closure: all you need to know
19 May 2026 – From EuroPCR 2026
This session provides a comprehensive guide to large-bore venous access and vessel closure techniques, emphasizing best practices and the advantages of ultrasound-guided suture mediated vessel closure compared to traditional figure-of-eight suture methods. It also addresses strategies to avoid and manage potential complications encountered during these procedures.
Align for the future with structural heart innovations - LIVE case and major trial updates
19 May 2026 – From EuroPCR 2026
Stay abreast of structural heart innovations with expert discussions on best-in-class transcatheter aortic valve implantation (TAVI) practices, including imaging, sizing, and procedural strategies. This session with LIVE case introduces the novel Myval Octapro+ transcatheter heart valve (THV), its design philosophy, and potential clinical benefits, along with...
Left main PCI treatment: how Ultreon 3.0 can improve decision making and achieve optimised outcomes
20 May 2026 – From EuroPCR 2026
This session explores how to optimise left main PCI through the integration of intracoronary imaging and physiology using Ultreon 3.0 software. It highlights how this innovative technology supports decision-making, procedural planning, and stent optimisation to improve outcomes in complex lesion management.
Expanding the horizon - Trials addressing unchartered territories in coronary and structural heart
20 May 2026 – From EuroPCR 2026
New clinical evidence is pushing coronary and structural heart therapy into areas that were previously uncertain or inconsistently defined, with multiple landmark trials now shaping future practice.
Among the studies discussed in this EuroPCR 2026 session, are SORT OUT XII, START YOUNG, BISCUSPID, LANDMARK 2 and RESTORE...
Beyond the horizon - Future of structural heart innovations and PCI
20 May 2026 – From EuroPCR 2026
Structural heart and coronary interventions are expanding rapidly, with innovation increasingly focused on managing complex anatomies and diversifying treatment strategies.
The PRISM-PCI toolkit is introduced as a framework to support decision-making in complex PCI, alongside advances in transcatheter valve therapies spanning mitral, tricuspid and pulmonary interventions, as...
Novelties in epicardial physiology: PPG explained in a simulated environment
20 May 2026 – From EuroPCR 2026
Understanding coronary physiology continues to evolve as new indices aim to refine how epicardial disease is assessed in daily practice.
The perfusion pressure gradient (PPG) index is introduced in this EuroPCR 2026 session as a novel approach to characterising epicardial coronary physiology. Rather than relying solely on...
Advancing mitral transcatheter edge-to-edge repair in complex lesions
20 May 2026 – From EuroPCR 2026
Learn how advanced imaging, careful anatomical assessment and tailored procedural strategies are helping expand the possibilities of mitral transcatheter edge-to-edge repair (M-TEER) in complex lesions.
Focusing on atrial secondary mitral regurgitation (SMR) and commissural mitral regurgitation, this EuroPCR 2026 session reviews evidence, showing that M-TEER can be...
Seeing differently, treating better: advanced imaging shaping modern structural heart practice
20 May 2026 – From EuroPCR 2026
This session explores the transformative role of advanced imaging, particularly 3D intracardiac echocardiography (ICE), in modern structural heart interventions. It provides practical insights into implementation, highlighting how these tools can enhance workflow efficiency and procedural confidence across transcatheter edge-to-edge repair (TEER), left atrial appendage (LAA) closure,...
High-risk PCI: how to optimise the result
19 May 2026 – From EuroPCR 2026
Focused on high-risk PCI, this session presents strategies to optimize procedural outcomes in complex cases. Discussions include contemporary approaches to challenging coronary anatomy, the role of balloon aortic valvuloplasty as a bridge to Impella-supported interventions, advanced mechanical support and thrombectomy in cardiogenic shock related to left...
From access to reperfusion: a procedural deep dive into pulmonary embolism
20 May 2026 – From EuroPCR 2026
From vascular access to reperfusion strategy, managing acute pulmonary embolism requires rapid decision-making, careful patient selection and increasingly sophisticated interventional techniques.
This EuroPCR 2026 session takes a procedural deep dive into contemporary pulmonary embolism management, focusing on thrombus aspiration techniques and the evolving role of computer-assisted vacuum...
TAVI for degenerated surgical aortic bioprotheses: procedural challenges
19 May 2026 – From EuroPCR 2026
This session addresses the procedural challenges inherent in transcatheter aortic valve implantation (TAVI) for degenerated surgical aortic bioprostheses. It covers high-risk valve-in-valve implantation cases as last-resort therapies, management of drifting bioprostheses, and interventions in failed small non-fracturable valves threatening coronary arteries. Techniques such as BASILICA and...
From left to right: different perspectives on heart failure management
19 May 2026 – From EuroPCR 2026
Exploring diverse perspectives on heart failure management, this session presents a range of complex clinical cases. Topics include facilitated treatment of post-myocardial infarction interventricular septal defects, left ventricular perforation following Impella placement, diagnostic challenges in shock scenarios, the implications of severe right ventricular dysfunction on left...
PRISM-PCI - From clarity to cure
20 May 2026 – From EuroPCR 2026
PRISM-PCI offers cutting-edge imaging innovations and treatment strategies aimed at optimizing complex PCI procedures. This session explores the 'leave nothing behind' concept with thin-strut bioresorbable scaffolds and sirolimus drug-coated balloons, updates on ultra thin-strut DES platforms, including the SORT OUT XII trial, and introduces a comprehensive...
Value of imaging for treatment of calcified lesions
19 May 2026 – From EuroPCR 2026
This session highlights the critical value of imaging in the treatment of calcified coronary lesions. It reviews techniques for lesion modification, including innovative balloon-based strategies and multimodality approaches for balloon-uncrossable calcified left main bifurcations. The session also discusses the tactical cracking of calcified plaques and strategies...